Publicaciones en las que colabora con ANGELES ALVAREZ RIBELLES (10)

2023

  1. Abacavir causes leukocyte/platelet crosstalk by activating neutrophil P2X7 receptors thus releasing soluble lectin-like oxidized low-density lipoprotein receptor-1

    British Journal of Pharmacology, Vol. 180, Núm. 11, pp. 1516-1532

2022

  1. Role of neutrophil extracellular traps in covid-19 progression: An insight for effective treatment

    Biomedicines, Vol. 10, Núm. 1

2021

  1. Abacavir Increases Purinergic P2X7 Receptor Activation by ATP: Does a Pro-inflammatory Synergism Underlie Its Cardiovascular Toxicity?

    Frontiers in Pharmacology, Vol. 12

  2. Hypercholesterolemic patients have higher eryptosis and erythrocyte adhesion to human endothelium independently of statin therapy

    International Journal of Clinical Practice, Vol. 75, Núm. 11

  3. The neutrophil secretome as a crucial link between inflammation and thrombosis

    International Journal of Molecular Sciences, Vol. 22, Núm. 8

2020

  1. Structural and functional basis for understanding the biological significance of p2x7 receptor

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-23

2018

  1. Abacavir induces arterial thrombosis in a murine model

    Journal of Infectious Diseases

2017

  1. Abacavir induces platelet-endothelium interactions by interfering with purinergic signalling: A step from inflammation to thrombosis

    Antiviral Research, Vol. 141, pp. 179-185

2015

  1. Differential effects of anti-TNF-α and anti-IL-12/23 agents on human leukocyte-endothelial cell interactions

    European Journal of Pharmacology, Vol. 765, pp. 355-365

2014

  1. Efavirenz induces interactions between leucocytes and endothelium through the activation of Mac-1 and gp150,95

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 4, pp. 995-1004